Global and domestic private equity funds, including Apax Partners, TPG Capital, TA Associates, and Kedaara Capital, are in talks to acquire...

The 51-year-old is now creating a ceramic wedding cake that's 12 meters (40 feet) high and 15 meters (50 feet) wide.

Three private equity– led investment platforms have been created specifically targeting the API space, while at least half a dozen transact...

The global crypto market cap declined to $1.62 trillion, about 4 per cent higher compared to the last day. However, the total crypto market...

While Brazil stagnates, Russia enters a recession and India struggles to implement economic reforms, the US is booming as energy prices plu...

Airtel though will be the anchor tenant on the portfolio under a lease with a 10-year initial term, the two companies said in a joint state...

Yog was in the news in 2011 for gifting $11 million to his professor Arthur Segel at Harvard Business School as 'guru dakshina'.

American Tower Company is believed to be leading race to buy 4,000 towers, followed by IHS Towers, ET reported quoting a person aware of th...

Bharti Airtel is expected to reach an agreement on the sale of its telecom towers in Nigeria for more than $1 billion within the next three...

The deal signals renewed interest by private equity funds to build commercial real estate assets in India as it offers annuity returns for ...

India’s largest listed tower company looks to strengthen its footprint to tap business from telecom companies looking to expand their netwo...

The company has been refinancing large parts of its debt pile by issuing overseas bonds, helping it to lower its net finance payouts.

Xander, which has invested over $1.2 billion locally, has signed a preliminary agreement and is working towards a final deal that is “not y...

Xander and Mapletree, are in the fray to acquire Shapoorji Pallonji's business park SP Infocity, in Chennai, valued at Rs 450 crore.

India’s IT mogul Azim Premji, and Bangladesh’s microcredit leader and Nobel Prize winner Mohammad Yusuf are among the all-time top 30 entre...

UCB, the Belgian maker of the allergy drug Zyrtec, agreed to buy Schwarz Pharma for E4.4bn ($5.6bn) in cash and stock to gain new medicines...